Actively Recruiting

All Genders
NCT06840860

Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)

Led by Institute of Tropical Medicine, Belgium · Updated on 2025-05-02

1000

Participants Needed

2

Research Sites

100 weeks

Total Duration

On this page

Sponsors

I

Institute of Tropical Medicine, Belgium

Lead Sponsor

U

University of Manitoba

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study aims to better understand how mpox is spreading in the DRC, how it affects different groups of people, and how well vaccines protect against it. The study is designed as a cross-sectional survey, meaning researchers will collect and analyze data from patients diagnosed with mpox at a single point in time. It will also use a case-control approach, comparing people who test positive for the virus to those who test negative, to identify risk factors and evaluate the effectiveness of the vaccine.

CONDITIONS

Official Title

Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Apply to be tested for VMPX at HGR or another test center.
  • Patients of all ages and sexes. However, minors under the age of 12 are excluded from questions on sex life.
  • The patient or his/her culturally acceptable representative is willing and able to give informed consent for participation in the study.
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Masina Mpox Treatment Center

Kinshasa, Masina, Democratic Republic of the Congo

Not Yet Recruiting

2

Masina Mpox Treatment Center

Kinshasa, Democratic Republic of the Congo

Actively Recruiting

Loading map...

Research Team

L

Laurens Liesenborghs, MD, PhD

CONTACT

S

Sarah Houben, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here